Kenvue Inc. is a pure-play consumer health company. Its brand portfolio includes AVEENO(R), BAND-AID(R) Brand Adhesive Bandages, JOHNSON'S(R), LISTERINE(R), NEUTROGENA(R), TYLENOL(R) and ZYRTEC(R). Kenvue Inc. is based in SKILLMAN, N.J.
Revenue (Most Recent Fiscal Year) | $15.46B |
Net Income (Most Recent Fiscal Year) | $1.03B |
PE Ratio (Current Year Earnings Estimate) | 21.63 |
PE Ratio (Trailing 12 Months) | 22.22 |
PEG Ratio (Long Term Growth Estimate) | 3.74 |
Price to Sales Ratio (Trailing 12 Months) | 3.06 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 4.66 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 16.61 |
Pre-Tax Margin (Trailing 12 Months) | 9.45% |
Net Margin (Trailing 12 Months) | 6.90% |
Return on Equity (Trailing 12 Months) | 20.87% |
Return on Assets (Trailing 12 Months) | 8.04% |
Current Ratio (Most Recent Fiscal Quarter) | 0.86 |
Quick Ratio (Most Recent Fiscal Quarter) | 0.60 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.63 |
Inventory Turnover (Trailing 12 Months) | 3.70 |
Book Value per Share (Most Recent Fiscal Quarter) | $5.04 |
Earnings per Share (Most Recent Fiscal Quarter) | $0.24 |
Earnings per Share (Most Recent Fiscal Year) | $1.14 |
Diluted Earnings per Share (Trailing 12 Months) | $0.55 |
Exchange | NYSE |
Sector | Consumer Defensive |
Industry | Household & Personal Products |
Common Shares Outstanding | 1.92B |
Free Float | 1.92B |
Market Capitalization | $46.89B |
Average Volume (Last 20 Days) | 19.51M |
Beta (Past 60 Months) | 1.02 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 0.17% |
Percentage Held By Institutions (Latest 13F Reports) | 97.64% |
Annual Dividend (Based on Last Quarter) | $0.82 |
Dividend Yield (Based on Last Quarter) | 3.36% |